Surgical Treatment With Concentrated Growth Factor for Multiple Papillary Losses
NCT ID: NCT03635931
Last Updated: 2019-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2017-07-30
2018-08-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Growth Factors in the Treatment of the Multiple Gingival Recessions
NCT05319938
Gingival Recession Treatment With Concentrated Growth Factor(CGF)
NCT03020732
CGF-Enhanced Autologous Pulp Transplantation in Mature Necrotic Teeth
NCT07314866
Comparison of De-Epithelialized Gingival Graft With or Without Platelet Rich Fibrin in Multiple Gingival Recessions
NCT06509867
Effect of Cyanoacrylate and Concentrated Growth Factor on Palatal Donor Site
NCT06459947
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This controlled, examiner-blinded, randomized clinical study included 160 teeth of 40 patients with 120 open embrasures which resulted from papillary loss in adjacent teeth in the anterior maxillary esthetic zone resulting in black triangles (BTs). The test group was formed of 20 patients with 60 adjacent papillary defects undergoing minimally invasive surgery for papillary regeneration with CGF. A control group was formed of 20 patients with 60 adjacent papillary defects who were not included surgical treatment. A total of 480 images obtained with the digital impressions method of each interdental papillary region in each patient were uploaded to a special software. Evaluations of the test group were made preoperatively and at 3, 6 and 12 months postoperatively. For the control group, oral hygiene instruction was provided. Control group is evaluated by the same procedure with test group but the surgical part is not performed. Lost interdental papillary area (PA)were calculated between the two central teeth, between the lateral and central teeth, and between the lateral and canine teeth prior to the treatment and at pro-treatment periods of 3, 6 and 12 months in both of the groups. In the test group, the percentage of papillary filling, the presence of keratinized gingiva, the thickness of papillary gingiva, blood thrombocyte count and MPV values were recorded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Concentrated Growth Factor
plaque control, scaling and root planing if required, surgical application of CGF
Concentrated Growth Factor
surgical treatment with CGF for papilla regeneration
Control Group
plaque control, scaling and root planing if required
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Concentrated Growth Factor
surgical treatment with CGF for papilla regeneration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The presence of a contact point in the maxillary anterior teeth
* optimal facial keratinized gingiva/ keratinized gingiva must be more than 2mm
Exclusion Criteria
* breast-feeding,
* palatal and gingival recession,
* attachment loss,
* high labial frenulum.
25 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara University
OTHER
Gazi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zeynep Turgut Çankaya
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
zeynep Turgut Çankaya, PhD,Dr
Role: PRINCIPAL_INVESTIGATOR
Gazi University, Faculty of Dentistry,Department of Periodontology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gazi University Faculty of Dentistry Department of Periodontology
Ankara, Çankaya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
36290600
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.